2
POPSPfizer’s Exubera: $4M In Sales! Bongs Away!
As a former contractor at the Terre Haute,IN Pfizer plant who worked on Exubra manufacturing,this comes as no big surprise.FDA requirements have kept this product off the consumer shelves for far too long.The waiting period for FDA product launch here in the United States basically killed Exubra in many ways.Imagine a production line in full operation at the end of which is a huge dumpster and you have Exubra.Research and development costs which are eventually passed on to the consumer that has to absorb that waiting period for a product which was available and in production 3 years ago.Instead , contract workers were laid off until the “White Elephant” got FDA’s blessing. Now ,there are more suitable,less expensive solutions geared to overtake Exubra available from the European market.This and other examples I could give just makes me too angry to continue,especially when Terre Haute Americans are the highest bankruptcy victims in America. Patrick Fournier Friarfox LLC